You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 274 No. 3, July 19, 1995 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Special Communications
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Lawyer Control of Internal Scientific Research to Protect Against Products Liability Lawsuits

The Brown and Williamson Documents

Peter Hanauer, LLB; John Slade, MD; Deborah E. Barnes; Lisa Bero, PhD; Stanton A. Glantz, PhD

JAMA. 1995;274(3):234-240.


Abstract

Objective.
—To understand how attorneys for the tobacco industry in general, and Brown and Williamson Tobacco Corporation (B&W) in particular, have responded to the threat of products liability litigation arising from smoking-induced diseases.

Data Sources.
—Documents from B&W, the British American Tobacco Company (BAT), and othertobacco interests provided by an anonymous source, obtained from Congress, or received from the private papers of a former BAT officer.

Study Selection.
—All available materials, including confidential reports regarding research and internal memoranda exchanged between tobacco industry lawyers.

Conclusions.
—The documents demonstrate that the tobacco industry in general, and B&W in particular, were very concerned about the threat of products liability lawsuits, and they illustrate some of the steps taken by lawyers at one company to avoid the discovery of documents that might be useful to a plaintiff in such a lawsuit. These steps included efforts to control the language of scientific discourse on issues related to smoking and health, to bring all potentially damaging internal scientific documents under attorney work product and attorney-client privilege to avoid discovery, to remove "deadwood" documents, and to insulate B&W from knowledge of potentially damaging scientific information from other BAT companies.

(JAMA. 1995;274:234-240)



Author Affiliations

From the Institute for Health Policy Studies, University of California, San Francisco (Mr Hanauer, Ms Barnes, and Drs Bero and Glantz), and the Department of Medicine, St Peter's Medical Center, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick (Dr Slade).


Footnotes

Reprint requests to Division of Cardiology, Box 0124, University of California, San Francisco, CA 94143-0124 (Dr Glantz).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Open Doorway to Truth: Legacy of the Minnesota Tobacco Trial
Hurt et al.
Mayo Clin Proc. 2009;84:446-456.
ABSTRACT | FULL TEXT  

Tobacco industry lawyers as "disease vectors"
Guardino and Daynard
Tobacco Control 2007;16:224-228.
ABSTRACT | FULL TEXT  

The Cigarette Controversy
Cummings et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:1070-1076.
ABSTRACT | FULL TEXT  

Challenging the epidemiologic evidence on passive smoking: tactics of tobacco industry expert witnesses
Francis et al.
Tobacco Control 2006;15:iv68-iv76.
ABSTRACT | FULL TEXT  

Every document and picture tells a story: using internal corporate document reviews, semiotics, and content analysis to assess tobacco advertising
Anderson et al.
Tobacco Control 2006;15:254-261.
ABSTRACT | FULL TEXT  

How the tobacco industry responded to an influential study of the health effects of secondhand smoke
Hong and Bero
BMJ 2002;325:1413-1416.
FULL TEXT  

Exposing Mr Butts' tricks of the trade
Cummings and Pollay
Tobacco Control 2002;11:i1-4.
FULL TEXT  

Tobacco Dependence Curricula in Acute Care Nurse Practitioner Education
Heath et al.
Am J Crit Care 2002;11:27-33.
ABSTRACT | FULL TEXT  

Science in regulatory policy making: case studies in the development of workplace smoking restrictions
Bero et al.
Tobacco Control 2001;10:329-336.
ABSTRACT | FULL TEXT  

The Cigarette Papers
Daynard
Journal of Health Politics, Policy and Law 1999;24:1400-1403.
 

Prying Open the Door to the Tobacco Industry's Secrets About Nicotine: The Minnesota Tobacco Trial
Hurt and Robertson
JAMA 1998;280:1173-1181.
ABSTRACT | FULL TEXT  

Tobacco Litigation: Issues for Public Health and Public Policy
Glantz et al.
JAMA 1997;277:751-753.
ABSTRACT  

Looking Through a Keyhole at the Tobacco Industry: The Brown and Williamson Documents
Glantz et al.
JAMA 1995;274:219-224.
ABSTRACT  

Nicotine and Addiction: The Brown and Williamson Documents
Slade et al.
JAMA 1995;274:225-233.
ABSTRACT  

Environmental Tobacco Smoke: The Brown and Williamson Documents
Barnes et al.
JAMA 1995;274:248-253.
ABSTRACT  

The Brown and Williamson Documents: Where Do We Go From Here?
Todd et al.
JAMA 1995;274:256-258.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.